02/24/2021
11:15 PM | BioLineRx (Filer)
| Form EFFECT
| |
02/23/2021
8:12 AM | BioLineRx (Filer)
| Form POS AM
| |
02/23/2021
6:02 AM | BioLineRx (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/23/2021
6:00 AM | BioLineRx (Filer)
| Form 20-F
Registration statement / Annual report / Transition report | |
02/12/2021
8:40 PM | Altium Capital Management LP (Filed by)
BioLineRx (Subject)
| Form SC 13G/A
| |
01/29/2021
5:19 AM | BioLineRx (Subject)
INTRACOASTAL CAPITAL, LLC (Filed by)
| Form SC 13G/A
| |
01/22/2021
3:21 PM | BioLineRx (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/21/2021
3:32 PM | BioLineRx (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/19/2021
8:46 PM | BioLineRx (Subject)
| Form FWP
| |
01/19/2021
4:01 PM | BioLineRx (Subject)
| Form FWP
| |
|
01/19/2021
4:00 PM | BioLineRx (Filer)
| Form 424B5
| |
01/11/2021
11:15 PM | BioLineRx (Filer)
| Form EFFECT
| |
01/06/2021
11:19 AM | BioLineRx (Subject)
SABBY MANAGEMENT, LLC (Filed by)
| Form SC 13G/A
| |
12/31/2020
3:37 PM | BioLineRx (Filer)
| Form F-3
Registration statement for securities of certain foreign private issuers | |
12/31/2020
3:31 PM | BioLineRx (Filer)
| Form 424B5
| |
12/16/2020
7:00 AM | BioLineRx (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/16/2020
5:02 AM | BioLineRx (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/23/2020
6:08 AM | BioLineRx (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/18/2020
6:09 AM | BioLineRx (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/13/2020
3:31 PM | BioLineRx (Filer)
| Form 424B5
| |
11/03/2020
3:39 PM | BioLineRx (Subject)
BioLineRx (Subject)
| Form SC 13G/A
| |
10/30/2020
6:09 AM | BioLineRx (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/29/2020
7:45 AM | BioLineRx (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/25/2020
3:33 PM | BioLineRx (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/25/2020
3:30 PM | BioLineRx (Filer)
| Form 424B5
| |
09/24/2020
3:30 PM | BioLineRx (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/19/2020
3:34 PM | BioLineRx (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/19/2020
6:08 AM | BioLineRx (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/12/2020
11:15 PM | BioLineRx (Filer)
| Form EFFECT
| |
08/06/2020
6:47 AM | BioLineRx (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/05/2020
11:15 PM | BioLineRx (Filer)
| Form EFFECT
| |
06/26/2020
3:30 PM | BioLineRx (Filer)
| Form F-1
Registration statement for securities of certain foreign private issuers | |
06/10/2020
7:02 AM | BioLineRx (Filer)
| Form D
Notice of Exempt Offering of Securities | |
06/10/2020
7:00 AM | BioLineRx (Filer)
| Form D
Notice of Exempt Offering of Securities | |
06/03/2020
7:33 AM | BioLineRx (Filer)
| Form 424B5
| |
06/03/2020
7:30 AM | BioLineRx (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/01/2020
7:05 AM | BioLineRx (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/28/2020
11:00 AM | BioLineRx (Filer)
| Form 424B5
| |
05/28/2020
10:56 AM | BioLineRx (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/27/2020
6:00 AM | BioLineRx (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/26/2020
1:54 PM | BioLineRx (Subject)
SABBY MANAGEMENT, LLC (Filed by)
| Form SC 13G
| |
05/26/2020
7:45 AM | BioLineRx (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/26/2020
7:10 AM | BioLineRx (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/20/2020
6:00 AM | BioLineRx (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/12/2020
6:07 AM | BioLineRx (Filer)
| Form 20-F
Registration statement / Annual report / Transition report | |
03/12/2020
6:00 AM | BioLineRx (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/05/2020
9:00 AM | BioLineRx (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/27/2020
6:00 AM | BioLineRx (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/19/2020
7:50 AM | BioLineRx (Filer)
| Form CT ORDER
| |
01/30/2020
6:00 AM | BioLineRx (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/22/2020
6:00 AM | BioLineRx (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/14/2020
6:00 AM | BioLineRx (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/13/2019
3:19 PM | BioLineRx (Filer)
| Form CT ORDER
| |
12/13/2019
6:00 AM | BioLineRx (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/05/2019
6:00 AM | BioLineRx (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/12/2019
5:21 AM | BioLineRx (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/05/2019
8:00 AM | BioLineRx (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/05/2019
7:00 AM | BioLineRx (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/25/2019
6:00 AM | BioLineRx (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/03/2019
6:00 AM | BioLineRx (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/06/2019
6:11 AM | BioLineRx (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/30/2019
6:00 AM | BioLineRx (Filer)
| Form 20-F/A
| |
07/02/2019
9:00 AM | BioLineRx (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/05/2019
6:00 AM | BioLineRx (Filer)
| Form 20-F/A
| |
05/28/2019
6:04 AM | BioLineRx (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/20/2019
11:26 AM | BioLineRx (Filer)
| Form CT ORDER
| |
05/14/2019
6:00 AM | BioLineRx (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/07/2019
6:00 AM | BioLineRx (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/28/2019
6:08 AM | BioLineRx (Filer)
| Form 20-F
Registration statement / Annual report / Transition report | |
03/28/2019
6:00 AM | BioLineRx (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/27/2019
6:01 AM | BioLineRx (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/21/2019
12:14 PM | BioLineRx (Filer)
| Form CT ORDER
| |
03/01/2019
4:12 PM | BioLineRx (Subject)
BIOTECHNOLOGY VALUE FUND L P (Filed by)
| Form SC 13D/A
| |
02/13/2019
11:15 PM | BioLineRx (Filer)
| Form EFFECT
| |
02/08/2019
3:46 PM | BioLineRx (Subject)
Senvest Management, LLC (Filed by)
| Form SC 13G
| |
02/08/2019
3:15 PM | BioLineRx (Subject)
Senvest Management, LLC (Filed by)
| Form SC 13G/A
| |
02/07/2019
11:00 AM | BioLineRx (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/05/2019
4:12 PM | BioLineRx (Filer)
| Form 424B5
| |
02/05/2019
8:00 AM | BioLineRx (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/04/2019
4:52 PM | BioLineRx (Filer)
| Form 424B5
| |
02/04/2019
3:30 PM | BioLineRx (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/04/2019
6:00 AM | BioLineRx (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/26/2018
3:11 PM | BioLineRx (Filer)
| Form F-3
Registration statement for securities of certain foreign private issuers | |
12/11/2018
6:00 AM | BioLineRx (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/04/2018
6:00 AM | BioLineRx (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/20/2018
6:00 AM | BioLineRx (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/08/2018
6:00 AM | BioLineRx (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/22/2018
6:00 AM | BioLineRx (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/19/2018
6:00 AM | BioLineRx (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/18/2018
1:56 PM | BioLineRx (Filer)
| Form CT ORDER
| |
10/11/2018
6:00 AM | BioLineRx (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/03/2018
5:03 AM | BioLineRx (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/13/2018
6:01 AM | BioLineRx (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/07/2018
6:00 AM | BioLineRx (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/01/2018
6:00 AM | BioLineRx (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/30/2018
6:00 AM | BioLineRx (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/18/2018
6:00 AM | BioLineRx (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/22/2018
6:00 AM | BioLineRx (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/17/2018
8:12 AM | BioLineRx (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/17/2018
7:57 AM | BioLineRx (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
